InvestorBrandNetwork Announces Want Money Got Money Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco [Video Edition]
LOS ANGELES (December 16, 2020) – via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, Chairman and CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), recently appeared on the Want Money Got Money Podcast, a series that helps entrepreneurs learn from the stories, secrets and skills of the world’s most brilliant and interesting startup founders and investors. The podcast, hosted by Author, Founder, Speaker and CEO Sam Kamani, is available for on-demand listening at https://samkamani.buzzsprout.com. During the interview, Climaco discussed the research of CNS Pharmaceuticals founder Dr. Waldemar Priebe into the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. He also provided an overview of the company’s lead drug candidate, Berubicin, which is proposed for the treatment of GBM. Berubicin has been evaluated in a Phase I clinical trial, where 44% of patients experienced a clinical benefit of stable disease or better, including one patient who experienced a durable complete response and remains cancer free 14 years after treatment. CNS has applied to the U.S. Food and Drug Administration to begin a Phase II clinical trial and expects to begin enrolling patients in this trial in the first quarter of 2021.
Duration: 1 min